Thomas J. Schaefer - 03 Jan 2023 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Financial Officer
Signature
Thomas Schaefer, by Attorney-in-fact, Solaeta Chan
Issuer symbol
RKDA
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 20:07:57 UTC
Next filing
02 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (Right to Buy) Award $0 +50,000 +46% $0.000000 159,000 03 Jan 2023 Common Stock 50,000 $0.2800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 1/3/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.